3D medical imaging is enabling healthcare professionals to more accurately diagnose ailments and disorders, and this technology continues to steadily grow, according to a new report by Allied Market Research.

The firm’s report, “3D medical imaging services Market by Technique, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” projects the global 3D imaging market to grow from $149.5 billion in 2017 to $236.8 by 2023,  for a compound annual growth rate of 6.7 percent.

According to Allied, the X-ray segment accounts for about 40 percent of the global market. From an applications standpoint, the firm expects the cardiology segment to grow the fastest in the next five years. As 3D imaging technology continues to improve, sectors such as gynecology and obstetrics will increasingly adopt these imaging techniques.

Here are some additional findings from the study:

• Diagnostic centers have dominated the global 3D medical imaging services market and are expected to grow at a CAGR of 5.8 percent through 2023.
• Research centers is expected to be the fastest growing segment in the market during the forecast period.
• North America continues to dominate the 3D medical imaging services market, in large part to the U.S. In the U.S., 3D medical imaging will grow at a CAGR of 4.4 percent through 2023.
• India is expected to be the fastest growing country in the Asia-Pacific 3D medical imaging services market during the forecast period.

According to Allied, key players in the global 3D medical imaging services market include: GE Company (GE Healthcare), Hitachi Ltd., Hologic, Planmeca, Materialise NV, Philips Healthcare, Siemens AG (Siemens Healthineers) and Carestream Health, and The Esaote Group, Canon Inc.